Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K8VA
|
||||
Former ID |
DIB019901
|
||||
Drug Name |
gemini
|
||||
Synonyms |
1R,25-dihydroxy-21-(3-hydroxy-3-methylbutyl)vitamin D3; KH
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539828] | ||
Structure |
Download2D MOL |
||||
Formula |
C32H54O4
|
||||
InChI |
InChI=1S/C32H54O4/c1-22-25(20-26(33)21-29(22)34)14-13-24-12-9-19-32(6)27(15-16-28(24)32)23(10-7-17-30(2,3)35)11-8-18-31(4,5)36/h13-14,23,26-29,33-36H,1,7-12,15-21H2,2-6H3/b24-13+,25-14-/t26-,27-,28?,29+,32-/m1/s1
|
||||
InChIKey |
WTQXZYVWLNPNEX-YEWRDARRSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Vitamin D receptor | Target Info | Agonist | [526995] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Vitamin D metabolism and pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.